CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 184 shares at $8.89 ($1,636)
- 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 18,000 shares (grant or award)
- 4 Grant or award CEO acquired 50,000 shares (grant or award)
- 4 Open-market sale EVP, CBO AND CTO sold 101 shares at $8.89 ($898)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,790 shares at $9.67 ($26,966)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 4,287 shares at $9.67 ($41,435)
- 4 Open-market sale EVP, CBO AND CTO sold 3,307 shares at $9.67 ($31,963)
- 4 Open-market sale EVP, CBO AND CTO sold 346 shares at $11.10 ($3,841)
- SC 13G/A Stake Amended Statement of Ownership
Page 12 of 37 · 731 filings